DNA Methylation-Based Method to Differentiate Malignant from Benign Thyroid Lesions-Reference-Cited by-同舟云学术

DNA Methylation-Based Method to Differentiate Malignant from Benign Thyroid Lesions

Published:2019-09-01 Issue:9 Volume:29 Page:1244-1254
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Barros-Filho Mateus Camargo¹,dos Reis Mariana Bisarro¹²,Beltrami Caroline Moraes¹,de Mello Julia Bette Homem¹,Marchi Fábio Albuquerque¹,Kuasne Hellen¹,Drigo Sandra Aparecida²,de Andrade Victor Piana³,Saieg Mauro Ajaj³,Pinto Clóvis Antonio Lopes³,Kowalski Luiz Paulo⁴,Rogatto Silvia Regina⁵

Affiliation:

1. International Research Center - CIPE—A.C.Camargo Cancer Center, São Paulo, Brazil.

2. Faculty of Medicine, University of Sao Paulo State—UNESP, Botucatu, Brazil.

3. Department of Pathology, A.C.Camargo Cancer Center, São Paulo, Brazil.

4. Department of Head and Neck Surgery and Otorhinolaryngology, A.C.Camargo Cancer Center, São Paulo, Brazil.

5. Department of Clinical Genetics, Vejle Hospital, Institute of Regional Health Research, University of Southern Denmark, Vejle, Denmark.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2018.0458

Reference54 articles.

1. Biologic and Clinical Perspectives on Thyroid Cancer

2. The Thyroid Nodule

3. New developments in the diagnosis and treatment of thyroid cancer

4. A Large Multicenter Correlation Study of Thyroid Nodule Cytopathology and Histopathology

5. The 2017 Bethesda System for Reporting Thyroid Cytopathology

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MeIS: DNA Methylation-Based Immune Response Signatures for Thyroid Nodule Diagnostics;The Journal of Clinical Endocrinology & Metabolism;2024-03-07

2. RUNX1 methylation as a cancer biomarker in differentiating papillary thyroid cancer from benign thyroid nodules;Epigenomics;2023-12

3. Epigenome-wide methylation and progression to high-grade cervical intraepithelial neoplasia (CIN2+): a prospective cohort study in the United States;BMC Cancer;2023-11-06

4. Advances and challenges in thyroid cancer: The interplay of genetic modulators, targeted therapies, and AI-driven approaches;Life Sciences;2023-11

5. Molecular basis and targeted therapy in thyroid cancer: Progress and opportunities;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-07